Faringosept #20

Faringosept instruction for use

Reed more and buy Faringosept

The preparation Faringosept is the representative of the pharmacological group of antiseptics for local application. It is used to treat the infectious inflammatory pathology of ENT organs.

Description of dosage form, composition

The preparation Faringosept is available in the form of a tablet for resorption. They have a round shape and a biconvex surface. The main active ingredient of the drug is ambazone monohydrate, its content in one tablet is 10 mg. It also includes auxiliary components, which include:
    Lactose monohydrate.
    Aromatizer lemon (in tablets with lemon flavor).
    Cocoa.
    Sucrose.
    Gum arabic.
    Magnesium stearate.
    Polyvidon K30.
Tablets Faryngosept are packaged in a blister for 10 pieces. Cardboard pack contains 1 or 2 blisters with tablets, as well as instructions for using the drug.

Therapeutic effects, pharmacokinetics

The main active component of the Faringosept tablets has an antiseptic effect. It leads to the death of a significant number of pathogenic (pathogenic) and conditionally pathogenic microorganisms, including staphylococci, resistant to antibacterial agents. After resorption of the Faringosept tablet, the active ingredient is not practically absorbed into the systemic bloodstream.

Indications for use

The use of Faringosept tablets is indicated for the treatment and prophylaxis of infectious and inflammatory pathologies of the oral mucosa (stomatitis), tonsils (tonsillitis), gums (gingivitis). Also, the drug is used to prevent the development of an infectious-inflammatory process after tooth extraction.

Contraindications to use

The only absolute contraindication for the use of Faringosept tablets is the individual intolerance of Ambazone or the auxiliaries of this medication.

Proper use, dosage

Farnigosept tablets are intended for resorption. The average therapeutic dosage for adults is 3-5 tablets, which dissolve during the day through approximately the same time intervals. The dose for children aged 3 to 7 years should not exceed 3 tablets per day.

Side effects

In general, Faringosept tablets are transferred quite well. Sometimes, after resorption, it is possible to develop a mild allergic reaction, which is mainly manifested by a rash on the skin and its itching.

Application features

Before using the drug, you should carefully read the instructions to it. After resorption of the Pharyngocept tablet, it is recommended to refrain from eating food and water for 3 hours, which will make it possible to obtain a more pronounced therapeutic effect. This drug is recommended for children not younger than 3 years. The possibility of using Pharyngosept tablets for pregnant and breastfeeding women is determined by the attending physician under strict medical conditions if the intended benefit to the mother exceeds the potential risks to the developing fetus or infant. The active component of the drug has no direct effect on the functional state of the structures of the nervous system. In the pharmacy network, Faringosept tablets are dispensed without a prescription. When there is any doubt about their correct use, it is recommended that you seek medical advice from a medical professional.

Overdose

Data on the overdose of Faringosept tablets in clinical practice have not been recorded to date.

Proper storage

The shelf life of Faringosept tablets is 4 years. It is important to keep them in intact packaging, protected from light, moisture and inaccessible to children at an air temperature of no more than + 25 ° C.